PMID- 35891859
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220729
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 14
IP  - 6
DP  - 2022 Jun
TI  - Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review.
PG  - e26180
LID - 10.7759/cureus.26180 [doi]
LID - e26180
AB  - Diabetes mellitus is a chronic metabolic disorder resulting in hyperglycemia and 
      microvascular and macrovascular complications in individuals globally. Type 2 
      diabetes mellitus (T2DM) is highly prevalent and accounts for 90% of patients. 
      Maintaining blood glucose concentration is essential to avoid severe 
      complications. Glycemic control is the optimal serum glucose concentration in 
      diabetic patients. It is necessary to identify factors affecting the glycemic 
      control of patients to prevent control and complications. We conducted this 
      systematic review to assess the factors affecting glycemic control among type 2 
      diabetes mellitus patients. Published literature between the years 2020 to 2022 
      was retrieved from PubMed, Science Direct, and Google Scholar using different 
      combinations of keywords: T2DM, Glycemic control, Poor, Good, Adequate, 
      Inadequate, Factors, Association, and Determinants. All original articles written 
      in the English language with full-text available and the value of glycemic 
      control defined were included. A total of 1866 studies were retrieved. After the 
      title, abstract, screening, and full-text screening, 12 studies were eligible. 
      The prevalence of poor glycemic control was high, and it ranged between 45.2% and 
      93% among the studies. The factors associated with glycemic control were 
      stratified into four categories: personal or body-related, clinical, 
      medication-related, and behavioral factors. There was a high prevalence of poor 
      glycemic control in all included studies. The glycemic control was associated 
      with various factors; some were related to the patient or medical conditions 
      while others were related to the behavior of the patients or the medication 
      administrated.
CI  - Copyright (c) 2022, Bin Rakhis et al.
FAU - Bin Rakhis, Saud A Sr
AU  - Bin Rakhis SA Sr
AD  - Family Medicine, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAU.
FAU - AlDuwayhis, Nawaf Mohammed
AU  - AlDuwayhis NM
AD  - Family Medicine, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAU.
FAU - Aleid, Naif
AU  - Aleid N
AD  - Family Medicine, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAU.
FAU - AlBarrak, Abdullah Nasser
AU  - AlBarrak AN
AD  - Family Medicine, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAU.
FAU - Aloraini, Abdullah Ahmed
AU  - Aloraini AA
AD  - Family Medicine, King Saud Medical City, Family Medicine Academy, Riyadh, SAU.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220621
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC9304683
OTO - NOTNLM
OT  - determinants
OT  - diabetes mellitus
OT  - factors
OT  - glycemic control
OT  - t2dm
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:01
PMCR- 2022/06/21
CRDT- 2022/07/27 02:15
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/07/27 02:15 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:01 [medline]
PHST- 2022/06/21 00:00 [pmc-release]
AID - 10.7759/cureus.26180 [doi]
PST - epublish
SO  - Cureus. 2022 Jun 21;14(6):e26180. doi: 10.7759/cureus.26180. eCollection 2022 
      Jun.